Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, G-Protein-Coupled | 3 | 2019 | 1242 | 0.650 |
Why?
|
| Lactates | 1 | 2019 | 398 | 0.590 |
Why?
|
| Primary Graft Dysfunction | 1 | 2017 | 112 | 0.530 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2017 | 125 | 0.510 |
Why?
|
| Kidney Failure, Chronic | 3 | 2017 | 2495 | 0.440 |
Why?
|
| Kidney Diseases | 3 | 2006 | 2098 | 0.350 |
Why?
|
| Macrophage Activation | 1 | 2013 | 552 | 0.340 |
Why?
|
| Receptors, Nicotinic | 1 | 2013 | 494 | 0.340 |
Why?
|
| Kidney Transplantation | 6 | 2017 | 4270 | 0.290 |
Why?
|
| Proteinuria | 3 | 2005 | 607 | 0.250 |
Why?
|
| Sepsis | 1 | 2019 | 2606 | 0.240 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2006 | 386 | 0.240 |
Why?
|
| Uric Acid | 2 | 2010 | 809 | 0.220 |
Why?
|
| Quinolinic Acid | 1 | 2023 | 67 | 0.220 |
Why?
|
| Antiporters | 3 | 2009 | 275 | 0.200 |
Why?
|
| Renin-Angiotensin System | 2 | 2005 | 737 | 0.190 |
Why?
|
| Albuminuria | 1 | 2005 | 660 | 0.180 |
Why?
|
| Biological Transport, Active | 2 | 2013 | 323 | 0.170 |
Why?
|
| Macrophages | 2 | 2013 | 5772 | 0.170 |
Why?
|
| Gout | 1 | 2006 | 620 | 0.160 |
Why?
|
| Fetus | 1 | 2006 | 1870 | 0.150 |
Why?
|
| Chloride-Bicarbonate Antiporters | 2 | 2009 | 103 | 0.140 |
Why?
|
| Hypertension | 3 | 2006 | 8626 | 0.140 |
Why?
|
| Anion Transport Proteins | 2 | 2009 | 142 | 0.130 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2016 | 81 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 1 | 2005 | 2233 | 0.130 |
Why?
|
| Bone Remodeling | 1 | 2017 | 577 | 0.110 |
Why?
|
| Osteoclasts | 1 | 2017 | 713 | 0.110 |
Why?
|
| Immediate-Early Proteins | 1 | 2016 | 444 | 0.110 |
Why?
|
| NF-kappa B | 2 | 2013 | 2485 | 0.100 |
Why?
|
| Niacin | 1 | 2013 | 116 | 0.100 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 2 | 2011 | 166 | 0.100 |
Why?
|
| Pyrimethamine | 1 | 2011 | 95 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 1946 | 0.090 |
Why?
|
| Sodium | 1 | 2016 | 1591 | 0.090 |
Why?
|
| Mineral Oil | 1 | 2010 | 21 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2013 | 596 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 643 | 0.090 |
Why?
|
| Animals | 19 | 2023 | 168764 | 0.080 |
Why?
|
| Interleukins | 1 | 2013 | 791 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 9550 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2009 | 334 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2019 | 14448 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 870 | 0.070 |
Why?
|
| Brain Death | 2 | 2001 | 360 | 0.070 |
Why?
|
| Ischemia | 2 | 2010 | 1909 | 0.070 |
Why?
|
| Xenopus laevis | 4 | 2016 | 964 | 0.070 |
Why?
|
| Bacteria | 1 | 2017 | 2209 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 586 | 0.070 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 452 | 0.060 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2006 | 61 | 0.060 |
Why?
|
| Kidney | 5 | 2023 | 7066 | 0.060 |
Why?
|
| Symporters | 2 | 2005 | 362 | 0.060 |
Why?
|
| Mice | 8 | 2023 | 81819 | 0.060 |
Why?
|
| Sequence Homology | 1 | 2006 | 197 | 0.060 |
Why?
|
| Eels | 1 | 2005 | 6 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 2216 | 0.060 |
Why?
|
| Organic Anion Transporters | 1 | 2006 | 101 | 0.060 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2005 | 64 | 0.060 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2005 | 66 | 0.060 |
Why?
|
| Fresh Water | 1 | 2005 | 82 | 0.060 |
Why?
|
| Oocytes | 4 | 2016 | 1169 | 0.060 |
Why?
|
| Survival Rate | 1 | 2019 | 12795 | 0.060 |
Why?
|
| Nephrons | 1 | 2006 | 165 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2005 | 180 | 0.060 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 276 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factors | 1 | 2023 | 5 | 0.060 |
Why?
|
| Sulfates | 1 | 2005 | 376 | 0.060 |
Why?
|
| Water-Electrolyte Balance | 1 | 2005 | 325 | 0.060 |
Why?
|
| Disease Progression | 3 | 2005 | 13632 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 4348 | 0.050 |
Why?
|
| Kidney Glomerulus | 1 | 2006 | 568 | 0.050 |
Why?
|
| Acidosis | 1 | 2005 | 271 | 0.050 |
Why?
|
| Bicarbonates | 3 | 2009 | 293 | 0.050 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2005 | 429 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2010 | 4137 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2005 | 366 | 0.050 |
Why?
|
| Insulin | 1 | 2016 | 6599 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 3 | 2009 | 918 | 0.050 |
Why?
|
| Tryptophan | 1 | 2023 | 483 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2005 | 547 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 1 | 2006 | 871 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 12240 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2006 | 9347 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2005 | 770 | 0.040 |
Why?
|
| Chlorides | 3 | 2009 | 666 | 0.040 |
Why?
|
| NAD | 1 | 2023 | 619 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 1514 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2747 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 2016 | 1984 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2005 | 6309 | 0.040 |
Why?
|
| RNA, Messenger | 6 | 2016 | 12768 | 0.040 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2000 | 333 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2017 | 100 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 17075 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1999 | 778 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2016 | 1884 | 0.030 |
Why?
|
| Humans | 15 | 2017 | 765968 | 0.030 |
Why?
|
| Anemia | 1 | 2005 | 1511 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 2033 | 0.030 |
Why?
|
| Isoantibodies | 1 | 1999 | 681 | 0.030 |
Why?
|
| Rats | 6 | 2016 | 23707 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2006 | 3046 | 0.030 |
Why?
|
| Graft Survival | 2 | 2010 | 3890 | 0.030 |
Why?
|
| Rats, Inbred Lew | 3 | 2001 | 1167 | 0.030 |
Why?
|
| Homeostasis | 1 | 2005 | 3336 | 0.030 |
Why?
|
| Smoking Cessation | 1 | 2005 | 2084 | 0.030 |
Why?
|
| Tissue Distribution | 2 | 2009 | 2266 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2006 | 4913 | 0.030 |
Why?
|
| Serotonin | 1 | 2017 | 1049 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 1999 | 1042 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2009 | 4165 | 0.020 |
Why?
|
| Aminosalicylic Acids | 1 | 2011 | 37 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2010 | 65188 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 3750 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 170 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2011 | 459 | 0.020 |
Why?
|
| Transplantation, Isogeneic | 2 | 2001 | 251 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2000 | 2395 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 1936 | 0.020 |
Why?
|
| Gene Expression | 3 | 2011 | 7584 | 0.020 |
Why?
|
| Maryland | 1 | 2010 | 278 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2010 | 413 | 0.020 |
Why?
|
| Pancreas | 1 | 2016 | 1700 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2009 | 3737 | 0.020 |
Why?
|
| DNA Primers | 2 | 2005 | 2825 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2010 | 386 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3690 | 0.020 |
Why?
|
| Smoking | 1 | 2005 | 9081 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2011 | 23601 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2010 | 574 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 348 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 1524 | 0.020 |
Why?
|
| Chemokine CCL2 | 2 | 2000 | 602 | 0.020 |
Why?
|
| G-Protein-Coupled Receptor Kinase 4 | 1 | 2006 | 3 | 0.020 |
Why?
|
| G-Protein-Coupled Receptor Kinases | 1 | 2006 | 5 | 0.020 |
Why?
|
| RNA, Complementary | 1 | 2005 | 46 | 0.020 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2006 | 50 | 0.020 |
Why?
|
| Heparin Antagonists | 1 | 2006 | 34 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2000 | 1132 | 0.020 |
Why?
|
| Cysts | 1 | 2011 | 684 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 1336 | 0.020 |
Why?
|
| Cytokines | 1 | 2001 | 7421 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 2669 | 0.020 |
Why?
|
| Mesna | 1 | 2005 | 62 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2006 | 26346 | 0.020 |
Why?
|
| Biotinylation | 1 | 2005 | 184 | 0.020 |
Why?
|
| Dopamine Antagonists | 1 | 2006 | 278 | 0.010 |
Why?
|
| Ifosfamide | 1 | 2005 | 233 | 0.010 |
Why?
|
| Zebrafish | 1 | 2016 | 3036 | 0.010 |
Why?
|
| Ion Transport | 1 | 2006 | 322 | 0.010 |
Why?
|
| Seawater | 1 | 2005 | 126 | 0.010 |
Why?
|
| Proline | 1 | 2005 | 453 | 0.010 |
Why?
|
| Codon | 1 | 2005 | 595 | 0.010 |
Why?
|
| Etoposide | 1 | 2005 | 636 | 0.010 |
Why?
|
| Inflammation | 2 | 2001 | 10850 | 0.010 |
Why?
|
| Cytarabine | 1 | 2005 | 698 | 0.010 |
Why?
|
| Dopamine Agonists | 1 | 2006 | 346 | 0.010 |
Why?
|
| Ligands | 1 | 2010 | 3273 | 0.010 |
Why?
|
| Obesity | 1 | 2005 | 13076 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2005 | 17594 | 0.010 |
Why?
|
| Candidiasis | 1 | 2005 | 371 | 0.010 |
Why?
|
| Cation Transport Proteins | 1 | 2005 | 325 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2010 | 18973 | 0.010 |
Why?
|
| Glycine | 1 | 2005 | 672 | 0.010 |
Why?
|
| Stomach | 1 | 2006 | 699 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 2745 | 0.010 |
Why?
|
| Biological Transport | 1 | 2005 | 2081 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 1500 | 0.010 |
Why?
|
| Lymphoma, Follicular | 1 | 2005 | 459 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 6220 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1831 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2011 | 8278 | 0.010 |
Why?
|
| Protein Transport | 1 | 2006 | 1939 | 0.010 |
Why?
|
| Neutropenia | 1 | 2005 | 893 | 0.010 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 622 | 0.010 |
Why?
|
| Reoperation | 1 | 2010 | 4294 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2005 | 1140 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 11022 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 5501 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1999 | 355 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2005 | 1272 | 0.010 |
Why?
|
| Heparin | 1 | 2006 | 1630 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 5020 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2000 | 694 | 0.010 |
Why?
|
| Fever | 1 | 2005 | 1603 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 15543 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3681 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 4108 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 9296 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2009 | 5125 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2000 | 1243 | 0.010 |
Why?
|
| Intestines | 1 | 2006 | 1906 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2010 | 4499 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 3634 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2000 | 927 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2005 | 1434 | 0.010 |
Why?
|
| Creatinine | 1 | 2001 | 1915 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 12403 | 0.010 |
Why?
|
| Male | 6 | 2016 | 363698 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 15398 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4562 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 13400 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2000 | 1995 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 10261 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18293 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 22332 | 0.010 |
Why?
|
| Adult | 3 | 2011 | 223044 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 9443 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 39193 | 0.000 |
Why?
|
| Time Factors | 1 | 2010 | 40065 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 8102 | 0.000 |
Why?
|
| Female | 3 | 2010 | 396112 | 0.000 |
Why?
|
| Neurons | 1 | 2005 | 9525 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1999 | 4209 | 0.000 |
Why?
|
| Blood Pressure | 1 | 2001 | 8532 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 11868 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2010 | 81514 | 0.000 |
Why?
|
| Mutation | 1 | 2005 | 30198 | 0.000 |
Why?
|
| Middle Aged | 1 | 2010 | 223009 | 0.000 |
Why?
|
Concepts
(220)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_